CITRYLL

Owner

Goods & Services

Pharmaceutical preparations for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis, organ damage due to sepsis, atherosclerosis and cardiovascular disease; antibodies for the treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis, organ damage due to sepsis, atherosclerosis and cardiovascular disease; antibodies for the prevention or treatment of autoimmune diseases; small molecules and synthetic peptides for the prevention and treatment of cancers, asthma, COPD, lupus, rheumatoid arthritis, vasculitis, idiopathic pulmonary fibrosis, lung disease, colitis, organ damage due to sepsis, atherosclerosis and cardiovascular disease